| APOC3 |
APOC3: Apolipoprotein C-III precursor |
TF |
TF, PRO1400: Serotransferrin precursor |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
C6 |
C6: Complement component C6 precursor |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
C3 |
|
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
ALB |
ALB: Uncharacterized protein ALB |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
MST1 |
IPI00555830 |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
AFM |
AFM, ALB2, ALBA: Afamin precursor |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
C2 |
C2: Complement C2 precursor |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
C4BPA |
C4BPA, C4BP: C4b-binding protein alpha chain precursor |
0.265 |
Evidence |
|
| APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
TF |
TF, PRO1400: Serotransferrin precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
ITIH2 |
IPI00619918 |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C3 |
|
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
MST1 |
IPI00555830 |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
HAMP |
HAMP, HEPC, UNQ487/PRO1003, LEAP1: Hepcidin precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
AFM |
AFM, ALB2, ALBA: Afamin precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
IGFALS |
IGFALS, ALS: Insulin-like growth factor-binding protein complex acid labile chai |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C4BPB |
C4BPB: C4b-binding protein beta chain precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C8G |
C8G: Complement component C8 gamma chain precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C2 |
C2: Complement C2 precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
HRG |
HRG: Histidine-rich glycoprotein precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
C4BPA |
C4BPA, C4BP: C4b-binding protein alpha chain precursor |
0.265 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
TF |
TF, PRO1400: Serotransferrin precursor |
0.265 |
Evidence |
|